Clear Channel Outdoor’s Return On Capital Employed Overview

Clear Channel Outdoor (NYSE:CCO) brought in sales totaling $545.43 million during Q1 according to data provided by Benzinga…

Clear Channel Outdoor (NYSE:CCO) brought in sales totaling $545.43 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 135.62%, resulting in a loss of $35.42 million. In Q4, Clear Channel Outdoor earned $99.44 million, and total sales reached $709.16 million.

What Is Return On Capital Employed?

Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company’s ROCE. A higher ROCE is generally representative of successful growth of a company and is a sign of higher earnings per share in the future. A low or negative ROCE suggests the opposite. In Q1, Clear Channel Outdoor posted an ROCE of 0.01%.

Keep in mind, while ROCE is a good measure of a company’s recent performance, it is not a highly reliable predictor of a company’s earnings or sales in the near future.

ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies. A relatively high ROCE shows Clear Channel Outdoor is potentially operating at a higher level of efficiency than other companies in its industry. If the company is generating high profits with its current level of capital, some of that money can be reinvested in more capital which will generally lead to higher returns and, ultimately, earnings per share (EPS) growth.

For Clear Channel Outdoor, the positive return on capital employed ratio of 0.01% suggests that management is allocating their capital effectively. Effective capital allocation is a positive indicator that a company will achieve more durable success and favorable long-term returns.

Analyst Predictions

Clear Channel Outdoor reported Q1 earnings per share at $-0.07/share, which beat analyst predictions of $-0.18/share.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Ultragenyx Reports Preliminary 2023 Revenue; Guidance For 2024 Revenue And Cash Usage; Pipeline Updates And 2024 Milestones; Sees FY23 Revenue $430-$435M Vs $435.9M Est.; Sees FY24 Revenue $500M-$530M Vs $523.86M Est.; Year-End 2023 Cash Balance Of ~$7…

Preliminary 2023 Total Revenue of $430 million to $435 million, Crysvita® Revenue of $325 million to $330 million and Dojolvi® revenue of $70 million to $71 million2024 expected Total Revenue guidance

RARE